Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.
Mitiushkina NV, Romanko AA, Preobrazhenskaya EV, Tiurin VI, Ermachenkova TI, Martianov AS, Mulkidjan RS, Sokolova TN, Kholmatov MM, Bizin IV, Ivantsov AO, Yatsuk OS, Zaitseva OA, Iyevleva AG, Kuligina ES, Imyanitov EN. Mitiushkina NV, et al. Among authors: martianov as. Cancer Med. 2022 Sep;11(17):3226-3237. doi: 10.1002/cam4.4686. Epub 2022 Mar 23. Cancer Med. 2022. PMID: 35322575 Free PMC article.
Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
Preobrazhenskaya EV, Shleykina AU, Gorustovich OA, Martianov AS, Bizin IV, Anisimova EI, Sokolova TN, Chuinyshena SA, Kuligina ES, Togo AV, Belyaev AM, Ivantsov AO, Sokolenko AP, Imyanitov EN. Preobrazhenskaya EV, et al. Among authors: martianov as. Int J Cancer. 2021 Jan 1;148(1):203-210. doi: 10.1002/ijc.33317. Epub 2020 Oct 6. Int J Cancer. 2021. PMID: 32997802
Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study.
Orlov SV, Iyevleva AG, Filippova EA, Lozhkina AM, Odintsova SV, Sokolova TN, Mitiushkina NV, Tiurin VI, Preobrazhenskaya EV, Romanko AA, Martianov AS, Ivantsov AO, Aleksakhina SN, Togo AV, Imyanitov EN. Orlov SV, et al. Among authors: martianov as. Transl Oncol. 2021 Aug;14(8):101121. doi: 10.1016/j.tranon.2021.101121. Epub 2021 May 21. Transl Oncol. 2021. PMID: 34030112 Free PMC article.
Molecular Analysis of Biliary Tract Cancers with the Custom 3' RACE-Based NGS Panel.
Mitiushkina NV, Tiurin VI, Anuskina AA, Bordovskaya NA, Shestakova AD, Martianov AS, Bubnov MG, Shishkina AS, Semina MV, Romanko AA, Kuligina ES, Imyanitov EN. Mitiushkina NV, et al. Among authors: martianov as. Diagnostics (Basel). 2023 Oct 10;13(20):3168. doi: 10.3390/diagnostics13203168. Diagnostics (Basel). 2023. PMID: 37891989 Free PMC article.
ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers.
Mulkidjan RS, Saitova ES, Preobrazhenskaya EV, Asadulaeva KA, Bubnov MG, Otradnova EA, Terina DM, Shulga SS, Martynenko DE, Semina MV, Belogubova EV, Tiurin VI, Amankwah PS, Martianov AS, Imyanitov EN. Mulkidjan RS, et al. Among authors: martianov as. Int J Mol Sci. 2023 Sep 2;24(17):13610. doi: 10.3390/ijms241713610. Int J Mol Sci. 2023. PMID: 37686416 Free PMC article.
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
Tiurin VI, Preobrazhenskaya EV, Mitiushkina NV, Romanko AA, Anuskina AA, Mulkidjan RS, Saitova ES, Krivosheyeva EA, Kharitonova ED, Shevyakov MP, Tryakin IA, Aleksakhina SN, Venina AR, Sokolova TN, Martianov AS, Shestakova AD, Ivantsov AO, Iyevleva AG, Imyanitov EN. Tiurin VI, et al. Among authors: martianov as. Int J Mol Sci. 2023 Jun 23;24(13):10530. doi: 10.3390/ijms241310530. Int J Mol Sci. 2023. PMID: 37445709 Free PMC article.
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
Martianov AS, Mitiushkina NV, Ershova AN, Martynenko DE, Bubnov MG, Amankwah P, Yanus GA, Aleksakhina SN, Tiurin VI, Venina AR, Anuskina AA, Gorgul YA, Shestakova AD, Maidin MA, Belyaev AM, Baboshkina LS, Iyevleva AG, Imyanitov EN. Martianov AS, et al. Int J Mol Sci. 2023 Mar 2;24(5):4868. doi: 10.3390/ijms24054868. Int J Mol Sci. 2023. PMID: 36902296 Free PMC article.
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.
Moiseyenko FV, Kuligina ES, Zhabina AS, Belukhin SA, Laidus TA, Martianov AS, Zagorodnev KA, Sokolova TN, Chuinyshena SA, Kholmatov MM, Artemieva EV, Stepanova EO, Shuginova TN, Volkov NM, Yanus GA, Imyanitov EN. Moiseyenko FV, et al. Among authors: martianov as. Int J Clin Oncol. 2022 May;27(5):850-862. doi: 10.1007/s10147-022-02128-6. Epub 2022 Feb 16. Int J Clin Oncol. 2022. PMID: 35171360 Free PMC article.
Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal.
Kuligina ES, Meerovich R, Zagorodnev KA, Kholmatov MM, Sokolova TN, Laidus TA, Romanko AA, Martianov AS, Anisimova MO, Zaitseva OA, Yatsuk OS, Yanus GA, Imyanitov EN. Kuligina ES, et al. Among authors: martianov as. Cancer Genet. 2021 Aug;256-257:165-178. doi: 10.1016/j.cancergen.2021.05.014. Epub 2021 May 28. Cancer Genet. 2021. PMID: 34186498